Victory Park Capital sells Enteris to SWK
SWK Holdings Corporation has acquired Enteris BioPharma from Victory Park Capital for $21.5 million. Enteris BioPharma is a New Jersey-based biotechnology company.
27 August 2019•7 mins read
SWK Holdings Corporation has acquired Enteris BioPharma from Victory Park Capital for $21.5 million. Enteris BioPharma is a New Jersey-based biotechnology company.
Mason Wells explores sale of KJ Holding, parent of lemonade brand Calypso, sources say
11 hours ago · 2 mins read
Stellex completes sale of UK gear maker David Brown Defence to Renk
11 hours ago · 2 mins read
Linden Capital Partners strikes deal to back AnewHealth alongside Nautic
12 hours ago · 2 mins read
Archimed completes carve-out of Standard BioTools’ microfluidics unit, now Biomark Scientific
12 hours ago · 1 min read
Blue Point’s RSI expands into Indiana with Wells Masonry add-on
12 hours ago · 2 mins read
McNally Capital’s Tenica acquires intelligence contractor Trinity Enterprise Services
12 hours ago · 1 min read
L Squared acquires vegetation manager Edko in first Fund V platform deal
13 hours ago · 2 mins read
